Tiangang Li to Cholestasis
This is a "connection" page, showing publications Tiangang Li has written about Cholestasis.
Connection Strength
1.721
-
A Gly-?-muricholic acid and FGF15 combination therapy synergistically reduces "humanized" bile acid pool toxicity in cholestasis mice. J Lipid Res. 2025 Dec; 66(12):100936.
Score: 0.942
-
Combining ASBT inhibitor and FGF15 treatments enhances therapeutic efficacy against cholangiopathy in female but not male Cyp2c70 KO mice. J Lipid Res. 2023 03; 64(3):100340.
Score: 0.778